Vivani Medical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Vivani Medical, Inc. (VANI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-23.49-25.65-13.89-12.77-14.88-33.59-35.09
Depreciation & Amortization0.400.360.380.350.160.400.44
Stock Based Compensation1.611.861.301.671.200.000.00
Change in Working Capital0.35-1.290.340.44-3.740.040.43
Change in Accounts Payable0.25-0.60-1.940.01-0.020.000.00
Change in Other Working Capital0.280.902.28-0.630.160.000.00
Other Operating Activities0.280.90-6.91-0.631.222.600.11
Net Cash from Operating Activities-20.79-23.70-18.79-10.95-16.82-27.63-29.81
Investing Activities
Capital Expenditures-0.56-0.89-0.34-0.57-0.33-0.49-0.16
Other Investing Activities0.000.000.000.000.400.000.00
Net Cash from Investing Activities-0.56-0.89-0.34-0.570.07-0.49-0.16
Financing Activities
Debt Repayment19.050.000.000.000.000.000.00
Common Stock Issued18.820.130.0211.626.6834.5125.94
Other Financing Activities-0.190.0055.370.000.000.000.00
Net Cash from Financing Activities19.050.1363.3911.628.6034.9926.60
Summary
Effect of Forex Changes on Cash-0.010.000.000.000.01-0.010.00
Net Change in Cash-2.29-24.4544.260.10-8.166.87-3.37
Cash at Beginning of Period21.9946.442.182.0811.334.477.84
Cash at End of Period19.6921.9946.442.183.1811.334.47
Free Cash Flow-21.34-24.59-19.13-11.52-17.15-28.12-29.97
Supplemental Disclosures
Income Taxes Paid0.000.000.000.000.000.000.00